Track topics on Twitter Track topics that are important to you
PARIS (dpa-AFX) - Sanofi reported that the detailed results from a Phase 3 trial showed Dupixent (dupilumab) monotherapy demonstrated a significant improvement in signs and symptoms of atopic derm...
Original Article: Sanofi Reports Positive Results From Phase 3 Dupixent StudyNEXT ARTICLE
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...